Meeder Asset Management’s Gladstone Commercial Corp GOOD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1
Closed -$11 948
2025
Q4
$11 Buy
+1
New +$11 ﹤0.01% 894
2025
Q3
Sell
-638
Closed -$9.14K 856
2025
Q2
$9.14K Buy
+638
New +$9.05K ﹤0.01% 633
2021
Q4
Sell
-11,277
Closed -$237K 1643
2021
Q3
$237K Hold
11,277
0.01% 671
2021
Q2
$254K Buy
11,277
+8,039
+248% +$172K 0.01% 680
2021
Q1
$63K Buy
+3,238
New +$61.2K ﹤0.01% 1034
2020
Q4
Sell
-3,237
Closed -$54K 2011
2020
Q3
$54K Hold
3,237
﹤0.01% 941
2020
Q2
$61K Buy
+3,237
New +$53.1K ﹤0.01% 883
2019
Q4
Sell
-1,133
Closed -$27K 2322
2019
Q3
$27K Sell
1,133
-691
-38% -$15.3K ﹤0.01% 1210
2019
Q2
$40K Buy
1,824
+590
+48% +$12.5K ﹤0.01% 1012
2019
Q1
$27K Sell
1,234
-342
-22% -$6.9K ﹤0.01% 1001
2018
Q4
$29K Sell
1,576
-392
-20% -$7.35K ﹤0.01% 953
2018
Q3
$38K Sell
1,968
-1,631
-45% -$32.1K ﹤0.01% 851
2018
Q2
$69.2K Sell
3,599
-2,238
-38% -$40.7K 0.01% 694
2018
Q1
$101K Buy
+5,837
New +$107K 0.01% 544

Other funds holding GOOD

Meeder Asset Management's GOOD Position: Q1 2026 in Review

Meeder Asset Management sold out of Gladstone Commercial Corp (GOOD) in Q1 2026, closing a stake of 1 share — an estimated $11 sold.

Meeder Asset Management first reported a position in GOOD in Q1 2018 and held it in 14 quarters. The position peaked at $254K in Q2 2021. 204 funds tracked by Wall St. Rank hold GOOD as of Q1 2026.

  • Meeder Asset Management reported no remaining Gladstone Commercial Corp position as of Q1 2026 after selling out during the quarter.
  • Meeder Asset Management sold 1 Gladstone Commercial Corp share in Q1 2026, an estimated $11.
  • Meeder Asset Management first reported a position in Gladstone Commercial Corp in Q1 2018 and held it in 14 quarters.
  • Meeder Asset Management's Gladstone Commercial Corp position peaked at $254K in Q2 2021.
  • 204 funds tracked by Wall St. Rank held Gladstone Commercial Corp as of Q1 2026.

Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.